These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35371270)

  • 41. Evaluation of the single-dose pharmacokinetics of bilastine in subjects with various degrees of renal insufficiency.
    Lasseter KC; Sologuren A; La Noce A; Dilzer SC
    Clin Drug Investig; 2013 Sep; 33(9):665-73. PubMed ID: 23873362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.
    Sinha VV; Kalikar MV; Mukhi JI; Giradkar AB; Sontakke S
    Perspect Clin Res; 2023; 14(4):180-186. PubMed ID: 38025284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria.
    Sneha B; Narasimhan M; Durai PCT; Ramakrishnan R
    Indian J Dermatol; 2024; 69(3):226-231. PubMed ID: 39119328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J; Mullol J; Valero A; Valiente R;
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.
    Vozmediano V; Lukas JC; Encinas E; Schmidt S; Sologuren A; Valiente R; Labeaga L; Campo C; Rodriguez M
    Eur J Pharm Sci; 2019 Feb; 128():180-192. PubMed ID: 30468868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Bilastine on Chronic Urticaria: A Systematic Review and Meta-Analysis.
    Xue X; Wang Q; Yang X; Tu H; Deng Z; Kong D; Liu W; Fan Z; Li N
    Int Arch Allergy Immunol; 2023; 184(2):176-185. PubMed ID: 36380619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antihistamines for the treatment of urticaria in Mexico].
    Larenas-Linnemann D; Sánchez-Borges M; Del Río-Navarro BE; Alonzo-Romero Pareyón Mde L; Maldonado-García CA; Mendoza-López E; Ortega-Martell JA; Sienra-Monge JJ; Medina-Ávalos MA; Rojo-Gutiérrez MI; Beirana-Palencia AM; Vargas-Correa JB; Báez-Loyola C; Ramírez-Segura RI; Guzmán-Perea MG
    Rev Alerg Mex; 2015; 62(3):157-74. PubMed ID: 26239325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bilastine for the relief of allergy symptoms.
    Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
    Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.
    Valk PJ; Simons R; Jetten AM; Valiente R; Labeaga L
    Aerosp Med Hum Perform; 2016 Jul; 87(7):622-7. PubMed ID: 27503042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac safety of second-generation H
    Cataldi M; Maurer M; Taglialatela M; Church MK
    Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.
    Leceta A; Sologuren A; Valiente R; Campo C; Labeaga L
    Drugs Context; 2017; 6():212500. PubMed ID: 28210286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.
    Sánchez J; Zakzuk J; Cardona R
    J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
    Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
    Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.
    Marín-Cabañas I; Berbegal-de Gracia L; de León-Marrero F; Hispán P; Silvestre JF
    Actas Dermosifiliogr; 2017 May; 108(4):346-353. PubMed ID: 28219634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
    Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria.
    Sarti L; Barni S; Giovannini M; Liccioli G; Novembre E; Mori F
    Pediatr Allergy Immunol; 2021 Jan; 32(1):153-160. PubMed ID: 32745323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Up-dosing Antihistamines in Chronic Spontaneous Urticaria: A Systematic Review of the Literature.
    Iriarte Sotés P; Armisén M; Usero-Bárcena T; Rodriguez Fernández A; Otero Rivas MM; Gonzalez MT; Meijide Calderón A; Veleiro B;
    J Investig Allergol Clin Immunol; 2021 Jul; 31(4):282-291. PubMed ID: 33030434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study.
    Ferrer M; Morais-Almeida M; Guizova M; Khanferyan R
    Clin Drug Investig; 2010; 30(1):15-34. PubMed ID: 19995095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The burden of chronic urticaria: French baseline data from the international real-life AWARE study.
    Guillet G; Bécherel PA; Pralong P; Delbarre M; Outtas O; Martin L; Pelvet B; Gharbi H; Giordano-Labadie F
    Eur J Dermatol; 2019 Feb; 29(1):49-54. PubMed ID: 30827942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.